Skip to main content
Autobound logo

Roche news and events in 2026

Roche news, hiring, executive changes and Reddit, Glassdoor, podcast and web signals in one place. Every row is dated and links to its source.

PublicMachinery Manufacturing10,000+ employeesroche.comLinkedIn

Dated updates
86
Last event
Sep 29, 2026
Open rolesSnapshot Sep 29, 2026
332

Overview

Roche by topic

Latest events

Latest Roche events

All Roche news →
  1. Executive hire
    Change in Roche’s Board of DirectorsChristophe Weber, Board of Directors
    globenewswire.com
  2. In development
    Positive interim data shows Roche’s sefaxersen significantly reduces proteinuria in people with IgA nephropathy (IgAN)Roche announced positive interim results from its phase III IMAgINATION study for its investigational drug sefaxersen, which met its primary endpoint of significantly reducing proteinuria in adults with IgA nephropathy (IgAN).
    globenewswire.com
  3. In development
    [Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase II results for dual GLP-1/GIP receptor agonist enicepatide in people living with type 2 diabetes and...Roche announced positive topline results from a Phase II clinical trial for its investigational drug enicepatide (CT-388), a dual GLP-1/GIP receptor agonist for adults with type 2 diabetes and overweight or obesity.
    globenewswire.com
  4. Launch
    European Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD)Roche's drug Susvimo® has been approved by the European Commission for the treatment of neovascular age-related macular degeneration (nAMD) in Europe.
    globenewswire.com
  5. In development
    CHMP recommends EU approval of Roche’s Ocrevus for children and adolescents with relapsing multiple sclerosisRoche's Ocrevus intravenous infusion has been recommended for approval by the European Medicines Agency's CHMP for treating children and adolescents with relapsing multiple sclerosis, with a final decision from the European Commission expected soon.
    globenewswire.com
  6. Partnership
    Roche, Dualitas team up to find bispecific drugs for immune diseases$1B · With Dualitas Therapeutics
    biopharmadive.com
  7. New location
    Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseasesWith Genentech
    globenewswire.com
  8. In development
    Roche’s Lunsumio-based regimen significantly improves progression-free survival in follicular lymphoma in phase III CELESTIMO studyRoche's phase III CELESTIMO study for its Lunsumio-based regimen met its primary endpoint, demonstrating a significant improvement in progression-free survival for patients with relapsed or refractory follicular lymphoma.
    globenewswire.com
  9. In development
    U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatmentsWith U.S. Food and Drug Administration
    globenewswire.com
  10. Partnership
    Roche Holding (SWX:ROP) Received FDA Clearance For An Alzheimer’s Blood TestWith Treeline Biosciences
    finance.yahoo.com

Showing 10 of 39 events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Roche with the Signal API

One POST /v1/companies/enrich call with roche.com returns every signal type for Roche, each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"roche.com","limit":20}'

Same industry

Companies related to Roche

Roche questions

What is the latest news on Roche?
On Sep 23, 2026, globenewswire.com reported: Change in Roche’s Board of Directors. This page tracks 39 news events for Roche since Jun 9, 2026, each with a date and a source link.
What is going on with Roche?
In the 90 days to Sep 30, 2026, Autobound tracked 27 news events, 4 hiring snapshots, 2 executive moves, 45 signals for Roche. The newest story is from Sep 23, 2026 (Executive hire), reported by globenewswire.com.
What else does Autobound track for Roche?
Beyond news and filings, Autobound lists 47+ signals for Roche from 5 sources: Glassdoor (15+), Website changes (15+), Patents (12), Web traffic (4), Podcasts (1). See the Roche signals page for the dated list.
Is Roche hiring right now?
Yes. As of Sep 29, 2026, Roche had 332 open roles, and Engineering had the most with 32.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →